Oncology & Cancer
Does intermittent fasting increase or decrease risk of cancer?
Research over the years has suggested intermittent fasting has the potential to improve our health and reduce the likelihood of developing cancer.
2 hours ago
0
0
News tagged with healthy cells
Oncology & Cancer
Understanding CAR-T cell therapy for cancer: Researcher explains how it works
For many doctors and researchers, immunotherapy that uses someone's own immune system to target and attack cancer cells is the next and best frontier of cancer treatment. Chimeric antigen receptor T-cell therapy, or CAR-T ...
Sep 3, 2024
0
1
Oncology & Cancer
Scientists discover how the body's killer cells attack cancer
Scientists are on the verge of a cancer breakthrough after working out how the body's immune system targets cells devastated by the disease.
Aug 29, 2024
0
75
Oncology & Cancer
Software tool analyzes cancer cells in biopsy slides
An innovative software tool could advance cancer pathology by providing diagnostic insights from tissue biopsies. The tool, called METI (Morphology-Enhanced Spatial Transcriptome Analysis Integrator), was developed by researchers ...
Aug 29, 2024
0
16
Immunology
Study identifies metabolic switch essential for generation of memory T cells and anti-tumor immunity
A Ludwig Cancer Research study has identified a metabolic switch in the immune system's T cells that is essential to the generation of memory T cells—which confer lasting immunity to previously encountered pathogens—and ...
Aug 24, 2024
0
68
Oncology & Cancer
Light-activated macrophages show increased appetite for cancer cells
The body has a veritable army constantly on guard to keep us safe from microscopic threats from infections to cancer. Chief among these forces is the macrophage, a white blood cell that surveils tissues and consumes pathogens, ...
Aug 12, 2024
0
36
Oncology & Cancer
Study shows a distinct pattern in protein production can predict severe side effects from skin cancer treatment
An activity pattern in certain genes responsible for building proteins known as spleen tyrosine kinases can predict which melanoma patients are likely to have severe side effects from immunotherapy designed to treat the most ...
Aug 8, 2024
0
59
